India-focused private equity fund manager True North has agreed to acquire Glenmark Pharmaceuticals’ orthopedic and pain management business in India and Nepal at an enterprise value of INR6.35 billion (approximately US$93 million). True North will invest through its fifth fund and rebrand the business as Integrace. The transaction is expected to close in two to three months.